Peptide record

TPDB03019

Antibacterial Hemolysis Toxicity standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB03019
Antibacterial Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 Peptipedia HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 18-aa standard-residue multi-activity (Antibacterial, Hemolysis, and Toxicity) peptide sequence curated from AntiBP3, Peptipedia, HemoPI, and other sources, with an available 3D structural model.
Sequence
GILKTIKSIASKLKRKAK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C90H171N27O22
NDCEQHMFPWYV
K
1983.52
11.90
7
0
7
+7
1.58
-0.328
119.44
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
2
A
1
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
3
I
2
L
6
K
0
M
0
F
0
P
2
S
1
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 2 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 3 L: 2 K: 6 M: 0 F: 0 P: 0 S: 2 T: 1 W: 0 Y: 0 V: 0
Chemical Descriptors
18 reviewed residue count
C90H171N27O22 sequence-only estimate (linear, free termini)
1983.52 sequence-only estimate (linear, free termini)
11.90 sequence-only estimate (linear, free termini)
+7 sequence-only estimate (linear, free termini)
1.58 sequence-only estimate (linear, free termini)
-0.328 sequence-only estimate (linear, free termini)
Evidence Records 4 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
923 µM
Hemolytic Cytotoxic
50% Hemolysis | 923 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin. | Biochim Biophys Acta | 2013
Evidence 2 Activity

Activity

50% Cell death
Toxicity
80 µM
Cytotoxic
50% Cell death | 80 | µM | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin. | Biochim Biophys Acta | 2013
Evidence 3 Activity

Activity

50% Cell death
Toxicity
132 µM
Cytotoxic
50% Cell death | 132 | µM | target cell: Human COS-7 cells

Target

Human COS-7 cells

Source & Reference

NA
DBAASP
Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin. | Biochim Biophys Acta | 2013
Evidence 4 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis